首页|橙皮苷对雌激素和孕激素诱导雌性大鼠乳腺增生的抑制作用

橙皮苷对雌激素和孕激素诱导雌性大鼠乳腺增生的抑制作用

扫码查看
目的 研究橙皮苷(Hsp)对乳腺增生(MGH)大鼠的治疗作用,及可能的作用机制.方法 将60只雌性大鼠随机分为空白组、模型组、对照组和低、中、高剂量实验组,每组10只.除空白组外,其余各组均肌内注射雌激素和孕激素诱导大鼠MGH模型.低、中、高剂量实验组分别灌胃给予25、50、100 mg·kg-1的Hsp;对照组灌胃给予5 mg·kg-1的他莫昔芬;空白组和模型组均灌胃给予等体积0.9%NaCl.6组大鼠每天给药1次,持续给药30 d.给药结束后,测量大鼠乳头高度和直径及子宫系数,用酶联免疫吸附试验法检测血清性激素含量,用试剂盒检测氧化应激指标的水平,用蛋白质印迹法检测相关蛋白的表达水平.结果 中、高剂量实验组和对照组、模型组、空白组大鼠的乳头直径分别为(1.41±0.20)、(1.18±0.21)、(1.23±0.20)、(1.75±0.13)和(1.02±0.06)mm,乳头高度分别为(1.62±0.24)、(1.41±0.19)、(1.47±0.16)、(1.87±0.32)和(1.23±0.14)mm,子宫系数分别为(0.55±0.08)、(0.37±0.05)、(0.41±0.04)、(0.72±0.11)和(0.34±0.03)mg·g-1,雌激素受体 α(ERα)相对表达水平分别为 0.54±0.05、0.13±0.02、0.13±0.03、0.89±0.08和0.10±0.02,孕酮受体(PR)相对表达水平分别为0.43±0.03、0.08±0.01、0.87±0.07、0.20±0.04 和 0.14±0.03,磷酸化细胞外调节激酶 1/2(ERK1/2)/ERK1/2 分别为 0.50±0.03、0.06±0.02、0.83±0.05、0.09±0.04和0.04±0.01.中、高剂量实验组和对照组的上述指标与模型组比较,在统计学上差异均有统计学意义(均P<0.05).结论 Hsp可减少大鼠乳头直径、高度及子宫系数,调节性激素水平,抗氧化应激,抑制ERα、PR和p-ERK1/2蛋白表达.
Inhibitory effects of hesperidin on estrogen-and progestin-induced mammary hyperplasia in female rats
Objective To investigate the therapeutic effect of hesperidin(Hsp)on mammary gland hyperplasia(MGH)rats and the possible mechanism.Methods Sixty female rats were randomly divided into blank,model,control and experimental-L,-M,-H groups.Except for blank group,all other groups were injected intramuscularly with estrogen and progestin to induce MGH model in rats.The experimental-L,-M and-H groups were given 25,50,100 mg·kg-1 Hsp by gavage.The control group was given 5 mg·kg-1 tamoxifen by gavage.The blank and control groups were given an equal volume of 0.9%NaCl by gavage.Six groups of rats were administered once a day for 30 days.After the administration,the height and diameter of nipples and the uterine coefficient were measured.The serum sex hormone content was detected using enzyme-linked immunosorbent assay,the levels of oxidative stress indicators were detected using corresponding kits,and the expressions of related proteins were detected using Western blot.Results The nipple diameters of rats in experimental-M and-H groups,control group,model group and blank group were(1.41±0.20),(1.18±0.21),(1.23±0.20),(1.75±0.13)and(1.02±0.06)mm;the nipple heights were(1.62±0.24),(1.41±0.19),(1.47±0.16),(1.87±0.32)and(1.23±0.14)mm;the uterine indexes were(0.55±0.08),(0.37±0.05),(0.41±0.04),(0.72±0.11)and(0.34±0.03)mg·g-1;the relative expression levels of estrogen receptor alpha(ERα)were 0.54±0.05,0.13±0.02,0.13±0.03,0.89±0.08 and 0.10±0.02;the relative expression levels of progesterone receptor(PR)were 0.43±0.03,0.08±0.01,0.87±0.07,0.20±0.04 and 0.14±0.03;the phosphorylated-extracellular-regulated kinase 1/2(ERK1/2)/ERK1/2 were 0.50±0.03,0.06±0.02,0.83±0.05,0.09±0.04 and 0.04±0.01,respectively.Compared with model group,the differences of above indexes in the experimental-M,-H groups and control group were statistically significant(all P<0.05).Conclusion Hsp could reduce nipple diameter,height,and uterine coefficient,regulate sex hormone levels,resist oxidative stress,and inhibit the expression of ERα,PR and p-ERK1/2 proteins in rats.

hesperidinestrogenmammary hyperplasiasuperoxide dismutaseextracellular-regulated kinase 1/2

杨阳、杨晓芬、黄培森、冷婕、杨凡、李永佳

展开 >

达州中医药职业学院针灸康复学院,四川达州 635000

达州市中心医院重症医学科,四川达州 635000

四川文理学院发展规划处,四川达州 635000

西南医科大学附属中医医院乳腺甲状腺血管外科,四川泸州 646000

川北医学院附属医院妇科,四川南充 637000

达州市中心医院中医科,四川达州 635000

展开 >

橙皮苷 雌激素 乳腺增生 超氧化物歧化酶 细胞外调节激酶1/2

四川省中医药局中医药科研专项

2021MS485

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(1)
  • 1
  • 2